13 Jun 2018 18:22
For immediate release | 13 June 2018 |
Â
Â
Â
Â
Â
Futura Medical plc
("Futura" or the "Company")
Â
Result of AGM
Â
Â
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, confirms that all resolutions were duly passed at its Annual General Meeting held today.
Â
Â
Â
For any further information please contact:
Â
Â
Futura Medical plc | Â |
James Barder, Chief Executive  | Tel: +44 (0)1483 685 670 |
mail to: james.barder@futuramedical.com | www.futuramedical.com |
  |  |
N+1 Singer (Nominated Adviser and Broker) | Â |
Aubrey Powell / Liz Yong  | Tel:+44 (0) 20 7496 3000 |
  |  |
For media enquiries please contact: Â | Â |
Buchanan | Â |
Mark Court / Sophie Wills / Tilly Abraham | Tel: +44 (0)20 7466 5000 |
Â
Â
Notes to Editors
Â
Futura Medical plc
Â
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Â
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
Â
www.futuramedical.com
Â